AURA BIOSCIENCES INC (AURA) Institutional Shareholders

AURA BIOSCIENCES INC (AURA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $638.70M in AURA holdings during the latest filing period.

Tcg Crossover Management, Llc is currently the largest disclosed institutional shareholder of AURA tracked by InsiderSet, reporting ownership valued at approximately $67.69M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $62.82M, representing an estimated loss of -7.18% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 60% of the total disclosed AURA value among the investors covered in this analysis. Major shareholders include Tcg Crossover Management, Llc, Suvretta Capital Management, Llc, Frazier Life Sciences Management, L.P., and several other long-term asset managers with concentrated positions in AURA BIOSCIENCES INC (AURA).

This page ranks the largest institutional AURA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

141

Total Reported Value

$638.70M

Largest Holder

Tcg Crossover Management, Llc

Largest Position

$67.69M

Insider Transactions (90d)

7

Latest Filing Quarter

Q2 2026

New Institutional Positions

141

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Tcg Crossover Management, Llc1.63%9,533,333$67,686,664$62,824,664-$4,862,000-7.18%
Suvretta Capital Management, Llc1.08%7,206,217$51,164,141$47,488,970-$3,675,171-7.18%
Frazier Life Sciences Management, L.P.1.10%7,100,000$50,410,000$46,789,000-$3,621,000-7.18%
Long Focus Capital Management, Llc1.48%5,119,582$36,349,032$33,738,045-$2,610,987-7.18%
Blackrock, Inc.0.00%4,707,674$33,424,486$31,023,572-$2,400,914-7.18%
Adage Capital Partners Gp, L.L.C.0.05%4,640,000$32,944,000$30,577,600-$2,366,400-7.18%
Caligan Partners Lp1.47%4,298,248$30,517,561$28,325,454-$2,192,107-7.18%
Vanguard Capital Management Llc0.00%4,100,342$29,112,428$27,021,254-$2,091,174-7.18%
Fcpm Iii Services B.V.3.84%4,053,775$28,781,803$26,714,377-$2,067,426-7.18%
Orbimed Advisors Llc0.45%3,333,333$23,666,664$21,966,664-$1,700,000-7.18%
Medicxi Ventures Management (Jersey) Ltd12.16%3,039,892$21,583,233$20,032,888-$1,550,345-7.18%
Nantahala Capital Management, Llc1.27%2,951,030$20,952,313$19,447,288-$1,505,025-7.18%
Ra Capital Management, L.P.0.15%2,500,000$17,750,000$16,475,000-$1,275,000-7.18%
Balyasny Asset Management L.P.0.03%2,354,619$16,717,795$15,516,939-$1,200,856-7.18%
Geode Capital Management, Llc0.00%1,754,721$12,462,919$11,563,611-$899,308-7.22%
Ecor1 Capital, Llc0.59%1,666,667$11,833,336$10,983,336-$850,000-7.18%
Redmile Group, Llc0.79%1,666,667$11,833,336$10,983,336-$850,000-7.18%
Trails Edge Capital Partners, Lp1.63%1,443,333$10,247,665$9,511,564-$736,101-7.18%
Foresite Capital Management Vi Llc1.47%1,333,334$9,466,671$8,786,671-$680,000-7.18%
State Street Corp0.00%1,222,984$8,683,186$8,059,465-$623,721-7.18%
Woodline Partners Lp0.03%1,210,183$8,592,299$7,975,106-$617,193-7.18%
Bellevue Group Ag0.17%1,166,667$8,283,336$7,688,336-$595,000-7.18%
Vivo Capital, Llc0.76%1,166,667$8,283,336$7,688,336-$595,000-7.18%
Acorn Capital Advisors, Llc1.80%929,077$6,596,447$6,122,617-$473,830-7.18%
Boothbay Fund Management, Llc0.12%906,356$6,435,128$5,972,886-$462,242-7.18%
Vanguard Portfolio Management Llc0.00%871,342$6,186,528$5,742,144-$444,384-7.18%
B Group, Inc.3.08%764,243$5,426,125$5,036,361-$389,764-7.18%
Stempoint Capital Lp0.88%714,280$5,071,388$4,707,105-$364,283-7.18%
Vanguard Fiduciary Trust Co0.00%637,204$4,524,148$4,199,174-$324,974-7.18%
Dimensional Fund Advisors Lp0.00%618,891$4,392,726$4,078,492-$314,234-7.15%
Millennium Management Llc0.00%617,467$4,384,016$4,069,108-$314,908-7.18%
Awm Investment Company, Inc.0.36%591,285$4,198,123$3,896,568-$301,555-7.18%
Northern Trust Corp0.00%549,462$3,901,181$3,620,955-$280,226-7.18%
Regency Capital Management Inc.\De1.53%540,395$3,836,804$3,561,203-$275,601-7.18%
Goldman Sachs Group Inc0.00%464,668$3,299,143$3,062,162-$236,981-7.18%
Price T Rowe Associates Inc0.00%278,471$1,978,000$1,835,124-$142,876-7.22%
Fmr Llc0.00%255,331$1,812,851$1,682,631-$130,220-7.18%
Morgan Stanley0.00%174,692$1,240,313$1,151,220-$89,093-7.18%
Renaissance Technologies LLCJim Simons0.00%174,200$1,236,820$1,147,978-$88,842-7.18%
Integral Health Asset Management, Llc0.05%170,000$1,207,000$1,120,300-$86,700-7.18%
Charles Schwab Investment Management Inc0.00%163,156$1,158,408$1,075,198-$83,210-7.18%
Xtx Topco Ltd0.01%149,931$1,064,510$988,045-$76,465-7.18%
Wellington Management Group Llp0.00%132,122$938,066$870,684-$67,382-7.18%
Quantinno Capital Management Lp0.00%130,656$927,658$861,023-$66,635-7.18%
Adar1 Capital Management, Llc0.04%130,152$924,079$857,702-$66,377-7.18%
Bank Of New York Mellon Corp0.00%118,593$842,009$781,528-$60,481-7.18%
Platinum Investment Management Ltd0.20%111,865$794,242$737,190-$57,052-7.18%
Aqr Capital Management Llc0.00%109,889$780,213$724,169-$56,044-7.18%
Qube Research & Technologies Ltd0.00%109,564$777,904$722,027-$55,877-7.18%
Bnp Paribas Financial Markets0.00%106,351$755,092$700,853-$54,239-7.18%
Showing 50 of 141

Frequently asked questions about AURA

  • Who owns the most AURA stock?

    The largest holders of AURA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AURA BIOSCIENCES INC (AURA).

  • Is AURA widely held by superinvestors?

    Many widely followed stocks like AURA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AURA is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.